Literature DB >> 16111633

CAML is a p56Lck-interacting protein that is required for thymocyte development.

David D Tran1, Contessa E Edgar, Karin L Heckman, Shari L Sutor, Catherine J Huntoon, Jan van Deursen, David L McKean, Richard J Bram.   

Abstract

Calcium modulating cyclophilin ligand (CAML) is a ubiquitously expressed protein implicated in T cell signaling, although its mechanism and physiologic role in the immune system are unknown. We show here that CAML is essential for peripheral T cell development. Inactivation of CAML in mouse thymocytes lowered the numbers of double-positive and single-positive thymocytes, concomitant with reduced positive and enhanced negative selection. We found that CAML interacts with p56Lck and appears to regulate subcellular localization of the kinase in both resting and T cell receptor (TCR)-stimulated cells. CAML-deficient cells displayed enhanced p56lck and ZAP-70 phosphorylation and increased IL2 production and cell death after TCR stimulation, suggesting that CAML may act as a negative regulator of p56lck. Our data establish a novel role for CAML as an essential mediator of T cell survival during thymopoiesis and indicate that its loss deregulates p56Lck signaling.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16111633     DOI: 10.1016/j.immuni.2005.06.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  21 in total

1.  Identification of a novel immunosubversion mechanism mediated by a virologue of the B-lymphocyte receptor TACI.

Authors:  Jason R Grant; Alexander R Moise; Wilfred A Jefferies
Journal:  Clin Vaccine Immunol       Date:  2007-05-30

Review 2.  The Ways of Tails: the GET Pathway and more.

Authors:  Nica Borgese; Javier Coy-Vergara; Sara Francesca Colombo; Blanche Schwappach
Journal:  Protein J       Date:  2019-06       Impact factor: 2.371

3.  CAML regulates Bim-dependent thymocyte death.

Authors:  C E Edgar; L D Lindquist; D L McKean; A Strasser; R J Bram
Journal:  Cell Death Differ       Date:  2010-03-19       Impact factor: 15.828

4.  Calcium-modulating cyclophilin ligand regulates membrane trafficking of postsynaptic GABA(A) receptors.

Authors:  Xu Yuan; Jun Yao; David Norris; David D Tran; Richard J Bram; Gong Chen; Bernhard Luscher
Journal:  Mol Cell Neurosci       Date:  2008-03-13       Impact factor: 4.314

Review 5.  Signaling defects in anti-tumor T cells.

Authors:  Alan B Frey; Ngozi Monu
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

6.  CAML loss causes anaphase failure and chromosome missegregation.

Authors:  Yu Liu; Liviu Malureanu; Karthik B Jeganathan; David Dinh Tran; Lonn D Lindquist; Jan M van Deursen; Richard J Bram
Journal:  Cell Cycle       Date:  2009-03-26       Impact factor: 4.534

7.  MUC1 mucin interacts with calcium-modulating cyclophilin ligand.

Authors:  Wei Guang; K Chul Kim; Erik P Lillehoj
Journal:  Int J Biochem Cell Biol       Date:  2008-12-14       Impact factor: 5.085

8.  Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.

Authors:  Vasundhara Varthakavi; Ellen Heimann-Nichols; Rita M Smith; Yuehui Sun; Richard J Bram; Showkat Ali; Jeremy Rose; Lingmei Ding; Paul Spearman
Journal:  Nat Med       Date:  2008-05-25       Impact factor: 53.440

9.  Effect of calcium-modulating cyclophilin ligand on human immunodeficiency virus type 1 particle release and cell surface expression of tetherin.

Authors:  Mariana G Bego; Mathieu Dubé; Johanne Mercier; Eric A Cohen
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

10.  Endogenous galectin-1 enforces class I-restricted TCR functional fate decisions in thymocytes.

Authors:  Scot D Liu; Chan C Whiting; Tamar Tomassian; Mabel Pang; Stephanie J Bissel; Linda G Baum; Valeri V Mossine; Françoise Poirier; Margaret E Huflejt; M Carrie Miceli
Journal:  Blood       Date:  2008-03-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.